Obstructive sleep apnea treated with custom-made bibloc and monobloc oral appliances: a retrospective comparative study by unknown
SLEEP BREATHING PHYSIOLOGYAND DISORDERS • ORIGINAL ARTICLE
Obstructive sleep apnea treated with custom-made bibloc
and monobloc oral appliances: a retrospective comparative study
Göran Isacsson1 & Clara Fodor1 & Magnus Sturebrand1
Received: 6 January 2016 /Revised: 6 June 2016 /Accepted: 28 June 2016 /Published online: 5 July 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Purpose The primary purpose of this hypothesis-generating
retrospective study was to compare the effect of monobloc and
bibloc (Narval™) appliances on the apnea–hypopnea index
(AHI) and the total cost of treatment during the first year of
treatment.
Methods Obstructive sleep apnea (OSA) subjects treated with
a monobloc or bibloc during two different time periods were
identified from medical records and data were extracted.
Subjects treated with either of the appliances passed the same
primary examination, follow-up visits, and follow-up poly-
graphic examination. A 1-year clinical follow-up was made
on the bibloc group.
Results The study analysis included 110 monobloc- and 55
bibloc-treated subjects with baseline mean AHI of 23 and 22,
respectively. AHI responders (AHI < 10 and/or a ≥50 %
reduction of baseline AHI) were seen at follow-up in 61 %
of the monobloc group and 56 % of the bibloc group. The
improvement of the AHI value was similar in the two groups,
with mean declines of 12.7 and 13.8, respectively. The ODI
(oxygen desaturation index), lowest SpO2, longest apnea, and
the mean Epworth sleepiness scale (ESS) score were signifi-
cantly reduced by 3.1 (monobloc) and 2.2 (bibloc), i.e., at the
same level for both groups. The total direct cost of treatment
for a 1-year treatment was 17 % higher for the bibloc-treated
subjects than for the monobloc-treated subjects.
Conclusions The results indicate that the monobloc and
bibloc appliances are equally effective but the cost of
treatment over 1 year was higher with the bibloc. However,
prospective randomized controlled trials are needed to ade-
quately test the assumption that the two treatment modalities
are equally effective.
Keywords Obstructive sleep apnea .Mandibular
advancement device . Cost of treatment . Treatment outcome
Introduction
The oral appliance (OA) is constructed so as to protrude the
mandible during sleep and is a well-established treatment
method of obstructive sleep apnea (OSA). The Food and
Drug Administration (FDA) classifies intraoral appliances
for snoring and/or OSA as class II (special controls) [1].
Oral appliances are indicated for use in patients with mild to
moderate OSAwho prefer them to continuous positive airway
pressure (CPAP) therapy, or who do not respond to, are not
appropriate candidates for, or who fail treatment attempts with
CPAP [2]. A number of different designs of the OA are fabri-
cated today, but there are two main types, namely the
monobloc and the bibloc appliance. The former is a solid
block of acrylic retained with clasps on the teeth and keeps
the jaws in a fixed closed protruded position. The bibloc has
separate constructions for the upper and lower jaws, equipped
with connectors that protrude the mandible. The bibloc appli-
ance allows the dentist to adjust the mandibular protrusion
chairside, while the monobloc appliance requires the support
of a dental technician. It is therefore assumed that the bibloc
appliance should take less time to fit.
In a systematic review, Ahrens et al. [3] presented two
studies comparing one-piece with two-piece appliances, in
which no difference in reduction of AHI. These results are in
contrast to the findings of a retrospective study by Lettieri
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et al. [4], who found significant advantages in AHI reduction
with adjustable compared with fixed appliances. In a systematic
review, Serra-Torres et al. [5] also concluded that adjustable and
custom-made mandibular advancement appliances give better
results than fixed and prefabricated appliances, and that
monobloc appliances give rise to more adverse events.
At the beginning of 2011, the Narval™ bibloc appliance
(hereafter, the bibloc appliance) was introduced to the
Swedish market. The compliance, efficiency, side effects,
and true cost of treatment for the bibloc in comparison with
the commonly usedmonobloc appliance were not known. The
primary purpose of this hypothesis-generating exploratory
retrospective study was to compare the effect of monobloc
and bibloc appliances on the apnea–hypopnea index (AHI),
and the cost of treatment during the first year of treatment. A
clinical- and questionnaire-based evaluation was also made on
the bibloc-treated group after 1 year.
Materials and methods
Subjects
Subjects had an established diagnosis of OSA and had been
referred to the Department of Orofacial Pain, Vastmanland
Hospital, Västerås, for treatment with an oral appliance. All
subjects, independent of subjective symptoms, who com-
menced treatment with monobloc appliances during the period
January 2009 to May 2010, and all subjects who commenced
treatment with bibloc appliances during the period January
2011 to January 2012 were included. The monobloc appliances
were all fabricated by Boxholm Tandteknik1 and the bibloc
appliances were manufactured by ResMed.2
Inclusion criteria were a diagnosis of OSAwith AHI ≥ 10,
and an oral status allowing retention of an appliance.
Exclusion criteria were snoring without OSA, maximal protru-
sion of less than 5 mm, and ongoing prosthodontic treatment.
The treatment in all phases including all technician costs
for all subjects was covered by the national health security
program (the annual cost for an adult person is at a maximum
of 1100 skr for all health services).
Study procedure
This is a clinical retrospective open effectiveness study de-
scribing polygraphic respiratory data and the cost of treatment
for the year after the commencement of treatment with
monobloc and bibloc appliances. All subjects treated with a
monobloc appliance were contacted by mail to obtain their
written informed consent to extract information from their
medical records. No further clinical study examination of the
monobloc group was made. Information was collected from
the subjects’ baseline data and during the year after commenc-
ing the treatment. Data from the bibloc group were gathered in
the same way but the subjects were also invited to participate
in a 1-year follow-up. The clinical management of all subjects,
independent of type of appliance, was the same at primary
examination, follow-up, and polygraphic examination at base-
line and follow-up.
All subjects visited the clinic, where a baseline clinical
examination was made and impressions of the jaws were
taken. A protrusion index protruded the mandible to 60–80 %
of the maximal protrusion. Treatment commenced 2–3 weeks
after the baseline examination and the appliance was fitted into
the mouth. If the retention was insufficient or needed
adjustment, it was returned to the technician for adjust-
ment or redesign.
An evaluation visit was scheduled 1–2 months after the
treatment commenced.Without any specified protocol, the sub-
ject was asked about snoring/apnea and the effect of the appli-
ance and ESS score collected. If required, the appliance was
adjusted. To adjust the degree of protrusion, the monobloc was
returned to the technician together with a new protrusion index
and an extra visit was then scheduled. Protrusion adjustment of
the bibloc appliance was made chairside. If the subject experi-
enced pain, discomfort, or problems with adapting to the appli-
ance, individual considerations were made.
Polygraphy was performed with concomitant use of the
appliance after the clinical evaluation. In cases of unsatisfac-
tory respiratory values (AHI > 10), the mandible was ad-
vanced if possible. Those who then had the appliance adjusted
were subjected to additional polygraphy.
The bibloc appliance treatment subjects were invited to
participate in a clinical follow-up examination and to respond
to a questionnaire 1 year after treatment commenced.
Somnopolygraphic examination
Polygraphy was completed at the Department of Physiology,
Vastmanland Hospital, Vasteras, as part of the clinical routine
for the examination of sleep apnea. All subjects underwent a
one-night respiratory baseline polygraphy (Embletta®,
ResMed) without any respiratory support. After 5–6 months
of use of the appliance, the polygraphy was repeated with the
appliance in place.
Cost of treatment
The calculation of a 1-year direct total cost of treatment for the
payer (the County Council) was based on the appliance fabri-
cation cost (technician cost) plus the dental office time, which
was standardized to 1 h for the first visit, 30min for the second
visit (treatment start), and 30 min for the third visit (follow-
1 Boxholm Tandteknik, Box 103, 590 10 Boxholm, Sweden.
2 ResMed Sweden AB, JanStenbecks Torg 17, 164 40 Kista, Sweden.
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up). All extra visits, including also those for dental laboratory
adjustment of protrusion, were set at 30 min each. The cost of
the dental office time was fixed at 2000 Swedish krona (SEK)
(€216, $235) per hour.
One-year follow-up clinical examination
and questionnaire
A clinical examination was made at the 1-year follow-up of the
bibloc appliance. The patient was asked to bite with amild force.
Occlusal stability in the intercuspal position was registered if the
molar teeth could keep a firm grip on an occlusal foil; if not, it
was classified as posterior open bite. Masseter and temporalis
muscle palpation tenderness and pain with jawmovements were
recorded with a yes/no response. The TMJ condylar movement,
tenderness to palpation, and sound- and jaw movement-related
pain were also registered as yes/no. The maximal mouth open-
ing (distance between the incisors) and the maximal range of
protrusion in the premolar region were measured.
The subjects completed a questionnaire with items on jaws,
teeth, snoring, and sleepiness. In addition, sleepiness was also
graded on an 11-point scale where (0 = no sleepiness; 10 =
worst imaginable sleepiness). The question BHow important is
the appliance for your and/or your bed partner’s well-being^
was measured using an 11-point Likert scale (0 = no impor-
tance; 10 = greatest possible importance). Patients rated the
change in their overall status since the beginning of the study
treatment on the seven-point Patient Global Impression of
Change (PGIC) scale (1 = very much improved; 2 =much im-
proved; 3 =minimally improved; 4 = no change; 5 =minimal-
ly worse; 6 =much worse; 7 = very much worse).
Statistics
Because of the exploratory and retrospective nature of the
study, no power calculation was made. Instead, reasonable
sized groups of subjects were included to allow proper
hypothesis generation. The results were presented as descrip-
tive statistics and tabulations. The primary variable was the
difference between the baseline and follow-up polygraphic
AHI value. Secondary variables were the cost of 1 year of
treatment, adverse events, and other polygraphic measures.
The Uppsala Regional Ethical Review Board, Sweden
approved the study 12th September 2012, #2012/307.
Informed consent was obtained from all subjects in both the
mono- as well as the bibloc groups.
Results
During the defined period, 160 subjects had a monobloc
appliance fitted. All but one subject (deceased) were sent a letter
asking for informed consent to extract data from their medical
records. Up to two follow-up letters were sent to those who did
not initially respond. Figure 1 illustrates the recruitment flow for
the 110 subjects whowere included in the study analysis. Ninety
percent of the subjects (n = 99) received an appliance made of
hard acrylic and the remaining 10 % received a soft elastomer
appliance. During the defined period, 116 subjects had a bibloc
appliance fitted (see Fig. 1). A total of 55 subjects were included
in the study and visited the clinic for the 1-year follow-up.
The baseline demographics, mandibular movement range,
and polygraphic data are described in Table 1. The proportion
of males was 79 % in the monobloc group and 80 % in the
bibloc group. The age range was 31–82 years (mean = 58) for
the monobloc group, and 37–76 years (mean = 57) for the
bibloc group. The two treatment groups were similar in most
baseline parameters except for the maximal protrusion range,
and consequently the degree of mandibular advancement with
the appliance. The bibloc appliance group had the mandible
protruded 3 mm on average more than the monobloc group.
CPAP treatment failure preceded 15 % of treatment in the
monobloc group and 8 % in the bibloc appliance group. One
subject in each group had been subjected to oropharyngeal
surgery. The mean time from starting the bibloc treatment to
the 1-year clinical follow-up ranged from 359 to 643 days
with a mean of 481 days (16 months).
At the beginning of treatment, 95 % of both the monobloc
and bibloc appliances could be fitted into the mouth and jaws;
the remaining 5 % of appliances required technician support
for adjustment or had to be remade.
At the evaluation visit, 11 subjects (10 %) in the monobloc
group needed to have their appliance adjusted to better control
the effect on apnea and/or snoring. These subjects were sub-
jected to a new protrusion index and the technician adjusted
the appliance accordingly. In the bibloc group, 21 subjects
(38 %) had the length of the connector rod exchanged, thereby
correcting the degree of protrusion. This was done chairside,
without the support of a technician.
At the evaluation visit, 78 % of the monobloc and 67 % of
the bibloc appliance-treated subjects were symptom free from
the jaws and teeth. The remaining subjects had various symp-
toms as shown in Table 2.
The use of an oral appliance significantly improved the
respiratory parameters in both appliance groups. The AHI
score reduced by a mean of 12.7 and 13.8 for the monobloc
and bibloc appliance groups, respectively. The daytime sleep-
iness score, measured by the ESS, was significantly reduced
with the use of the appliances (Table 3).
Based on polygraphic data at follow-up, 57 subjects (52 %)
in the monobloc group got an AHI < 10. Those with AHI ≥ 10
were recalled to the clinic and the mandibular protrusion was
advanced if possible. As a consequence, 16 subjects had a
second polygraphy, with an end result of 67 (61 %) AHI
responders (AHI < 10 and/or 50 % reduction of baseline
AHI) registered (Fig. 2).
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Polygraphic examination of the bibloc group revealed 30
subjects (55 %) with an AHI < 10 with four subjects referred
for a second polygraphic examination. A total of 31 (56 %)
were classified as AHI responders.
During the year after starting the appliance treatment, the
number of extra visits to the clinic was 0–6 occasions for both
groups (mean = 1.17 for the monobloc group, 1.0 for the
bibloc group). The total direct cost of treatment for the payer
over 1 year could then be calculated as SEK 7270 (€786,
$854) for a monobloc-treated subject and SEK 8500 (€920,
$999) (∼17 % higher) for a bibloc-treated subject (Table 4) To
note, the fabrication cost was fixed independent from number
of adjustments to be done by the technician.
At the 1-year follow-up, the predefined questions revealed
that one third of the subjects had stiffness/tiredness of the jaws
and one fifth had orofacial pain and difficulties fitting the teeth
after waking up (Table 5). The mean score in response to the
question BHow important is the appliance for you/your bed
partner’s well-being^ was 8.7 (SD 2.3) on the 11-point Likert
scale (0 = no importance; 10 = greatest possible importance).
The overall status at the 1-year follow-up since the beginning
of treatment was rated at least Bmuch improved^ by 89 % of
the subjects and none of the subjects scored worse on the
PGIC scale. At the 1-year clinical examination, the most com-
mon clinical signwas TMJ sound andmasseter and temporalis
muscle palpation tenderness. A posterior open bite occurred in
four of the subjects (Table 6).
Discussion
The results of the present retrospective hypothesis-generating
study indicate that the monobloc and bibloc appliances show
Treated with a monobloc-appliance
(n = 160)
Deceased  (n = 1)
Declined informed consent (n = 19)
Didn´t  respond to mail (n = 16)
Records suitable for analysis 
(n = 146)
Declined follow-up polygraphy  
n=14
n=36
Included in the analysis of the medical records
(n = 110)
Treated with a bibloc-appliance
(n = 116)
• Declined invitation to evaluation visit n = 22
• Unknown address n = 1
Invited to 1-year follow-up examination 
(n = 78)
• Declined follow-up polygraphy n = 10
• The oral appliance replaced by CPAP after evaluation visit n = 16
• Treated with gastric bypass – cancelled the oral appliance n = 2
• Family dog ate the appliance – can not afford a new one n = 1
• Bibloc device replaced by a monobloc appliance n = 4
• Did not tolerate an oral appliance n = 3
• Does not use the appliance of unspecified reason n = 2






Fig. 1 Recruitment schedule of
the subjects treated with
monobloc and bibloc appliances
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the same level of efficiency in reducing apnea–hypopnea
events, sleepiness, and the degree of side effects. There was
one major difference, namely the cost of treatment, with the
bibloc appliance being ∼17 % more expensive than the
monobloc appliance over 1 year. However, the results should
be treated with caution for a number of reasons: the retrospec-
tive study design, the subjects were not recruited identically,
the withdrawal rate was substantial, the study was not blinded
and polygraphy was done and not polysomnograhpy, the ad-
herence was not tracked, and the subjects were not randomly
allocated to a treatment group.
Both the monobloc and bibloc appliances significantly
reduced the AHI by a mean of about 12–14 events per hour,
which is the same magnitude previously reported in both
individual studies and systematic reviews [3, 6–8].
In a Cochrane meta-analysis, Lim et al. [9] analyzed cross-
over studies comparing active oral appliances with control
appliances and found a reduction of AHI value by a mean of
15.15 events per hour. In parallel group studies, a mean reduc-
tion of 10.78 was noted. In studies comparing oral appliances
with no treatment, the AHI improvement was a mean of 11
events per hour (95 % CI, 8–15) [10]. Vecchierini et al. [11]
used Narval bibloc appliances in 369 OSA patients and found
AHI reduction means of 7, 15, and 25 for mild, moderate, and
severe OSA, respectively. This highlights the importance of
presenting efficacy data based on OSA severity.
In a systematic review, Ahrens et al. [3] presented two
studies [12, 13] comparing one-piece with two-piece appli-
ances, in which no difference in reduction of AHI was found.
Rose et al. [13] compared the Silencer®Herbst-type appliance
with a Karwetzky activator on patients with mild OSA in a
crossover study. Both appliances reduced the RDI value by 9
and 11 events per hour, respectively. In a crossover study,
Bloch et al. [12] evaluated a monobloc and a Herbst appliance
inmoderate OSA patients. Although the reduction of AHI was
similar, with 14–15 events per hour, the patients preferred the
monobloc to the Herbst construction. These results are in con-
trast to the findings of a retrospective study by Lettieri et al.
[4], who found significant advantages in AHI reduction with
adjustable compared with fixed appliances. They also present-
ed the results grouped by grade of severity and noted that in
mild OSA, the effects of the two types of appliances were
similar. In a systematic review, Serra-Torres et al. [5] conclud-
ed that adjustable and custom-made mandibular advancement
appliances give better results than fixed and prefabricated
appliances, and that monobloc appliances give rise to more
Table 1 Baseline characteristics









BMI 28 (4.6) 28 (4.2)
ESS 11 (5.1) 10 (4.2)
Characteristics of somnopolygraphy
ODI 21 (11.1) 20 (13.0)
AHI 23 (11.2) 22 (14.8)
Lowest SpO2 (%) 81 (6.4) 82 (6.2)
Longest apnea (sec) 46 (20.0) 42 (23.2)
Characteristics of mandibular protrusion
Maximal mandibular PTR range (mm) 10 (2.6) 12 (2.8)
Mandibular PTR with appliance (mm) 6 (2.0) 9 (2.1)
Proportion of appliance-guided PTR in relation to max PTR (%) 67 (9.0) 73 (5.6)
BMI body mass index, ESS Epworth sleepiness scale, ODI oxygen desaturation index, AHI apnea hypopnea
index, SpO2 oxygen saturation, PTR protrusion
Table 2 Symptoms of the teeth/






No subjective symptoms 86 (78) 37 (67)
A lesser degree of symptoms, which did not reduce the use of the appliance 14 (13) 9 (16)
Moderate degree of symptoms, which reduced the use of the appliance 5 (5) 7 (13)
Severe symptoms, which did not allow the use of the appliance 1 (1) 2 (4)
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adverse events. Objective polygraphic registrations are crucial
as described byMarklund et al. [14] who evaluated fixed OAs
incrementally advanced in response to the clinical observa-
tion. Whether or not adjustable oral appliances improve the
effect more than monobloc appliances remains uncertain and
prospective randomized controlled trial evaluations are
required.
In the present study, 61 % percent of the monobloc group
and 56 % of the bibloc group were classified as responders.




vs. with the use of an
appliance
Monobloc appliance Bibloc appliance
Mean difference (SD) 95 % CI pa Mean difference (SD) 95 % CI pa
AHI 12.7 (11.6) 10.5;14.8 0.000 13.8 (14.8) 9.8;17.8 0.000
AI 8.3 (9.1) 6.6;10.1 0.000 8.0 (1.6) 4.8;11.3 0.000
ODI 11.0 (11.3) 8.9;13.2 0.000 12.2 (13.7) 8.4;16.1 0.000
Lowest SpO2 (%) 3.0 (6.1) 1.7;4.2 0.000 2.1 (5.6) 0.5:3.6 0.000
Longest apnea (sec) 15.2 (19.4) 11.1;19.3 0.000 11.0 (20.0) 5.0;17.0) 0.001
ESS 3.1 (4.0) 2.2;3.9 0.000 2.6 (4.3) 1.0:4.1 0.002
AHI apnea hypopnea index, AI apnea index, ODI oxygen desaturation index, SpO2 oxygen saturation, ESS Epworth
sleepiness scale
a p value reflects the difference within the treatment group
Monobloc group
n = 6 (6%)
AHI <10 and/or > 50% reduction of 
baseline
n = 57 (52%)
1st polygraphic follow-up
n = 110
n = 47 (43%)
AHI >10 and AHI < 50% reduction of 
baseline






n = 8 (16%)
AHI <10
AHI <10 and/or > 50% reduction of 
baseline
n = 30 (55%)
1st polygraphic follow-up
n = 55
n = 17 (31%)






No additional polygraphy made
AHI >10 and < 50% reduction of 
baseline
AHI <10 AHI >10 and  > 50% reduction of 
baseline
AHI >10 and < 50% reduction of 
baseline
AHI >10 and  > 50% reduction of 
baseline
Fig. 2 Polygraphic outcome
following treatment with
monobloc and bibloc appliances
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reported by Bloch et al. [12] for the Herbst bibloc appliance.
The reason for the diverging results depends on a number of
factors, including the severity of OSA, the degree of mandib-
ular advancement, and the degree of vertical increase, as well
as insufficient statistical power of the studies. Treatment ef-
fects tend to be greater in crossover trials than in parallel group
studies, and the effects in trials of short duration are greater
than in those in longer studies [15].
The ESS scores improved significantly in our study, with a
mean reduction of 3.1 and 2.6 for the monobloc and bibloc
groups, respectively. In a meta-analysis of randomized con-
trolled parallel group studies, Lim et al. [9] compared active
and controlled oral appliances showing an improvement of the
ESS score by –2.09. Qaseem et al. [10] found that oral appli-
ances improved the ESS score by 1.2 and 1.95 points, com-
pared with no treatment and sham treatment, respectively.
However, their meta-analysis did not include the more recent
publication by Marklund et al. [16]. At a 4-month follow-up,
they found that the ESSwas significantly improved in both the
active and the placebo appliance groups although the differ-
ence between the groups was not significant.
Martinez-Gomis et al. [17] followed patients using a
Herbst-type bibloc appliance over 5 years and noticed that
both symptoms and technical complications were more
frequent during the first year of treatment, with a mean of
3.0 unscheduled visits. In our study, means of 1.17 and 1.0
extra visits were found for the monobloc and bibloc appliance
groups, respectively. Although the difference in unscheduled
visits may depend on differences in the strength of the con-
structions, it certainly depends on the variation in routine at
the clinic and perhaps the variation in the primary advance-
ment of the mandible at the start of the treatment. A potentially
higher threshold for adjusting a monobloc appliance may also
affect the number of visits. The timeframe for the cost analysis
in the present study was only 1 year and of course the devices
durability over a number of years may affect the cost in any
direction. In Lim et al.’s Cochrane study [9], participants giv-
en the active oral appliance suffered side effects more fre-
quently than those given the control appliance. In our study,
one third responded that they had tiredness/stiffness of the
jaws that frequently created difficulties in fitting their teeth
after waking up. The most alarming objective finding of our
study was the development of a posterior open bite in four of
the 55 bibloc-treated patients after 1 year (themonobloc group
did not go through a 1-year clinical follow-up). This high-
lights the need for a regular clinical check when mandibular
advancement appliances are used.
The results of our study revealed a cost difference of SEK
1230 (GBP 95, $145, €132) over 1 year between the
monobloc and bibloc appliances. For the payer, the GBP 95
difference may be of some importance as the two types of
appliances are equally effective.
Table 4 The mean total
treatment direct cost in
Swedish crowns, skr,
during one 1-year con-
sidering both the techni-










Cost for extra visits




Monoblock 2100 4000 1.17 1.17*0.5*2000 = 1170 skr 7270 skr
Biblock 3500 4000 1.0 1.0*0.5*2000 = 1000 skr 8500 skr
a Cost of dental office per hour was set to 2000 skr. Calculated dentist time—visit 1: 1 h for information, clinical
examination, protrusion index, impression; visit 2: 0.5 h for fitting in the appliance; visit 3: 0.5 h for the follow-up, which
sum up to 2 h. All extra visits calculated to 30 min
Table 5 Positive response to a series of predefined questions on
subjective symptoms at 1-year follow-up by the 55 subjects treated with
a bibloc appliance
n (%)
Stiffness/tiredness of the jaws 19 (35)
Difficulty in opening the mouth or chewing 6 (11)
TMJ sounds at chewing 10 (18)
Orofacial pain 11 (20)
Difficulty fitting the teeth after waking up 12 (22)
Difficulty fitting the teeth in the daytime 2 (4)
Disturbed by my own snoring 4 (7)
My snoring disturbs others 18 (33)
Disturbed/woken up by my own apnea 2 (4)
Bed partner worried about my apnea 3 (6)
Usually wake up during the night 35 (64)
Table 6 The outcome of the clinical examination at the 1-year follow-





Posterior open bite 3 (6) 1 (2)
Masseter and temporalis muscle palpation
tenderness
8 (15) 8 (15)
TMJ palpation tenderness 1 (2) 4 (7)
Impaired translation of condyle 2 (4) 2 (4)
TMJ sound 9 (16) 5 (9)
TMJ pain at jaw movement 2 (4) 2 (4)
Jaw muscle pain at jaw movement 1 (2) 2 (4)
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Comment
Although retrospective, this sizeable study makes a useful contribution to
an ongoing area of debate. The popular trend is increasingly in favor of
adjustable appliances despite a lack of adequate trial-based evidence. The
findings of this report are that there is no difference between adjustable
and non-adjustable oral appliances except, importantly, in terms of cost.
These data are a reminder that evidence fromwell designed and adequate-
ly powered RCTs is still required. Until then, the case for the superiority
of adjustable devices remains unproven and clinical guidelines should
reflect this.Timothy QuinnellCambridge, UK
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